DE69935140D1 - Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren - Google Patents

Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren

Info

Publication number
DE69935140D1
DE69935140D1 DE69935140T DE69935140T DE69935140D1 DE 69935140 D1 DE69935140 D1 DE 69935140D1 DE 69935140 T DE69935140 T DE 69935140T DE 69935140 T DE69935140 T DE 69935140T DE 69935140 D1 DE69935140 D1 DE 69935140D1
Authority
DE
Germany
Prior art keywords
humans
animals
repair
treatment
webts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69935140T
Other languages
English (en)
Other versions
DE69935140T2 (de
Inventor
R Henderson
Tarek Hammad
Medhat Soliman
Barbara Corson
Louis Lipiello
Robert Henderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutramax Laboratories Inc
Original Assignee
Nutramax Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27375912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69935140(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/249,335 external-priority patent/US6451771B1/en
Application filed by Nutramax Laboratories Inc filed Critical Nutramax Laboratories Inc
Publication of DE69935140D1 publication Critical patent/DE69935140D1/de
Application granted granted Critical
Publication of DE69935140T2 publication Critical patent/DE69935140T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DE69935140T 1998-06-05 1999-06-03 Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren Expired - Lifetime DE69935140T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8820598P 1998-06-05 1998-06-05
US88205P 1998-06-05
US09/249,335 US6451771B1 (en) 1999-02-12 1999-02-12 Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
US249335 1999-02-12
US27488199A 1999-03-23 1999-03-23
US274881 1999-03-23
PCT/US1999/012152 WO1999062459A2 (en) 1998-06-05 1999-06-03 Agents and methods for protection, treatment and repair of connective tissue

Publications (2)

Publication Number Publication Date
DE69935140D1 true DE69935140D1 (de) 2007-03-29
DE69935140T2 DE69935140T2 (de) 2007-05-31

Family

ID=27375912

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935140T Expired - Lifetime DE69935140T2 (de) 1998-06-05 1999-06-03 Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren

Country Status (12)

Country Link
US (2) US8846118B2 (de)
EP (2) EP1083929B1 (de)
JP (1) JP4739522B2 (de)
AT (1) ATE353671T1 (de)
AU (2) AU770010B2 (de)
CA (1) CA2333755C (de)
CY (1) CY1107598T1 (de)
DE (1) DE69935140T2 (de)
DK (1) DK1083929T3 (de)
ES (1) ES2278447T3 (de)
PT (1) PT1083929E (de)
WO (1) WO1999062459A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492349B1 (en) * 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
WO2001012206A2 (de) * 1999-08-13 2001-02-22 Heinrich Wieland Soja-glycine extracten und aromatase-hemendern zur positiven beeinflussung von kollagen
FR2813195B1 (fr) 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
CA2433714C (en) * 2001-01-05 2009-03-03 Kyowa Hakko Kogyo Co., Ltd. Arthritis preventing or treating agent
WO2002098449A1 (fr) * 2001-06-01 2002-12-12 Nippon Meat Packers, Inc. Medications pour lesions des articulations et aliments fonctionnels
US7285570B2 (en) 2003-04-17 2007-10-23 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue
KR101629517B1 (ko) * 2007-06-01 2016-06-13 교와 핫꼬 바이오 가부시키가이샤 경구 조성물
WO2010146078A2 (en) * 2009-06-16 2010-12-23 Bergen Teknologioverføring As Novel uses of hydroxyproline compositions
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US9421234B2 (en) * 2011-05-20 2016-08-23 Nutramax Laboratories, Inc. Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9333242B2 (en) * 2012-01-19 2016-05-10 Hybrid Medical, Llc Topical therapeutic formulations
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
US9231977B2 (en) * 2013-12-23 2016-01-05 Nokia Technologies Oy Method and apparatus for providing collaborative privacy policies for a shared device
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB856493A (en) * 1957-10-04 1960-12-21 Pfizer & Co C Therapeutic compositions comprising tetracycline antibiotics
FR2193M (fr) * 1962-09-10 1963-12-09 Lipha Nouveau médicament pour le traitement des maladies infectieuses.
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
EP0662838A4 (de) * 1992-09-25 1996-07-24 Autoimmune Inc Verfahren zur behandlung rheumatoider arthritis mittels typ-ii-kollagen.
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
US5827874A (en) 1995-05-05 1998-10-27 Meyer; Hans Methods of treating pain and inflammation with proline
US6255295B1 (en) * 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
FR2770777B1 (fr) * 1997-11-10 2000-02-25 Fabre Pierre Dermo Cosmetique Composition synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline ainsi que leurs applications en nutritherapie et en cosmetologie
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals

Also Published As

Publication number Publication date
WO1999062459A2 (en) 1999-12-09
WO1999062459A9 (en) 2000-04-27
EP2272535A1 (de) 2011-01-12
US20100105632A1 (en) 2010-04-29
PT1083929E (pt) 2007-05-31
AU770010B2 (en) 2004-02-12
AU2009202256A1 (en) 2009-07-02
ATE353671T1 (de) 2007-03-15
EP1083929A2 (de) 2001-03-21
CY1107598T1 (el) 2013-03-13
EP1083929B1 (de) 2007-02-14
JP2002516829A (ja) 2002-06-11
CA2333755A1 (en) 1999-12-09
JP4739522B2 (ja) 2011-08-03
US8846118B2 (en) 2014-09-30
WO1999062459A3 (en) 2000-02-24
DK1083929T3 (da) 2007-06-11
EP1083929A4 (de) 2002-11-27
US8753697B2 (en) 2014-06-17
AU2009202256B2 (en) 2011-09-22
US20090087503A1 (en) 2009-04-02
DE69935140T2 (de) 2007-05-31
CA2333755C (en) 2012-11-27
AU4411599A (en) 1999-12-20
ES2278447T3 (es) 2007-08-01

Similar Documents

Publication Publication Date Title
DE69935140D1 (de) Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren
DE69638351D1 (de) Sowie zur resektion des distalen und vorderen femurs
AU3142597A (en) Dha-pharmaceutical agent conjugates
ATE241334T1 (de) Mittel zur förderung des haarwachstums
FI954654A (fi) Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen
DE69506289D1 (de) Gefässprothesen sowie Vorrichtung zum Anbringen
IL115405A0 (en) Compositions and methods for treating mast-cell mediated conditions
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE69820997D1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
HK1120211A1 (en) Agents and methods for protection, treatment and repair of connective tissue
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
BR9707252A (pt) Composições para o cuidado com tecidos incluindo poliolefinas dispersáveis e métodos para usar as mesmas
FI950909A (fi) Rasvahappojohdannaisia
EP1109548A4 (de) Zusammensetzungen und verfahren zur behandlung und vorbeugung von knochenkrankheiten unter verwendung von tocotrienole
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
EP0938901A4 (de) Medizinische zusammensetzungen zur behandlung von lebererkrankungen
AU5774699A (en) Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
GB2317109B (en) A therapeutic composition for the treatment and repair of connective tissue in mammals
EP0921803A4 (de) Verfahren zur vorbeugung und behandlung von pestvirus-infektionen und anverwandte erkrankungen
AU3855397A (en) Braces for dentifacial functional orthopaedic and periodontal treatment
EP1089731A4 (de) Zusammensetzungen und verfahren zur behandlung von erhöhtem blutcholesterolspiegel
AU6252699A (en) Composition and method for treating allergic diseases
HUP0102995A3 (en) Agents and method for the protective treatment of wood

Legal Events

Date Code Title Description
8363 Opposition against the patent